pocketful logo
Fortis Healthcare Ltd logo

Fortis Healthcare Ltd

NSE: FORTIS BSE: 532843

867.70

(3.55)%

Tue, 03 Feb 2026, 06:56 am

Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • No need to calculate the sustainability of Fortis Healthcare's dividends in 3 years as they are not expected to pay a notable one for India.
    • Unable to evaluate Fortis Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
    • Unable to evaluate Fortis Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.

    future

    thumbs up icon

    Pros

    • Fortis Healthcare is expected to become cash flow positive in 2 years.
    • Fortis Healthcare's earnings are expected to grow significantly at over 20% yearly.
    • Fortis Healthcare's earnings growth is expected to exceed the India market average.
    • Fortis Healthcare's earnings growth is expected to exceed the low risk savings rate of 7.2%.
    • An improvement in Fortis Healthcare's performance (ROE) is expected over the next 3 years.
    • Fortis Healthcare's revenue growth is expected to exceed the India market average.
    thumbs up icon

    Cons

    • Fortis Healthcare's earnings are expected to decrease over the next year.
    • Fortis Healthcare's net income is expected to decrease over the next 2 years.
    • Fortis Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
    • Performance (ROE) is not expected to exceed the current IN Healthcare industry average.
    • Fortis Healthcare's revenue is expected to increase but not above the 50% threshold in 2 years time.
    • Fortis Healthcare's revenue is expected to grow by 8.8% yearly, however this is not considered high growth (20% yearly).

    health

    thumbs up icon

    Pros

    • Fortis Healthcare is profitable, therefore cash runway is not a concern.
    • Fortis Healthcare is profitable, therefore cash runway is not a concern.
    • The level of debt compared to net worth has been reduced over the past 5 years (33.8% vs 18.8% today).
    • Interest payments on debt are well covered by earnings (EBIT is 4.5x coverage).
    • Fortis Healthcare's level of debt (18.8%) compared to net worth is satisfactory (less than 40%).
    thumbs up icon

    Cons

    • Fortis Healthcare's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
    • Operating cash flow is negative therefore debt is not well covered.
    • Debt is not covered by short term assets, assets are 0.8x debt.
    • Fortis Healthcare's long term commitments exceed its cash and other short term assets.
    • High level of physical assets or inventory.

    management

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • The average tenure for the Fortis Healthcare board of directors is less than 3 years, this suggests a new board.
      • The average tenure for the Fortis Healthcare management team is less than 2 years, this suggests a new team.

      past

      thumbs up icon

      Pros

      • Fortis Healthcare has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
      thumbs up icon

      Cons

      • Fortis Healthcare has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
      • Fortis Healthcare's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
      • Fortis Healthcare used its assets less efficiently than the IN Healthcare industry average last year based on Return on Assets.
      • Fortis Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
      • Fortis Healthcare has become profitable in the last year making it difficult to compare the IN Healthcare industry average.

      value

      thumbs up icon

      Pros

      • Fortis Healthcare is good value based on assets compared to the IN Healthcare industry average.
      • 532843 outperformed the Market in India which returned -14.5% over the past year.
      • BSE:532843 is up 5.4% along with the Healthcare industry (5.4%) over the past month.
      thumbs up icon

      Cons

      • Fortis Healthcare's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
      • Fortis Healthcare's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
      • Fortis Healthcare is poor value based on expected growth next year.
      • Fortis Healthcare is overvalued based on earnings compared to the IN Healthcare industry average.
      • Fortis Healthcare is overvalued based on earnings compared to the India market.
      • 532843 underperformed the Healthcare industry which returned 9.1% over the past year.
      • BSE:532843 is up 5.4% underperforming the market in India which returned 8% over the past month.

      Open Your Free Demat Account Now!

      Step into a world of zero fees and limitless opportunities!

      pocketful logo

      2022-25 Pocketful. All rights reserved, Built with in India

      Version -5.76

      app image 1app image 2

      Explore

      Calculatorsfooter arrow down icon
      Popular Calculatorsfooter arrow down icon
      Group Stocksfooter arrow down icon

      Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800